Tenaya Therapeutics (NASDAQ: TNYA) boosts share pool in revised equity plan
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Tenaya Therapeutics, Inc. amended and restated its 2021 Equity Incentive Plan after stockholder approval at the May 27, 2026 annual meeting. The plan now includes a one-time increase of approximately 3% of outstanding shares, adding 6,509,966 shares reserved for equity awards, and revises the annual evergreen provision to a 4% of outstanding shares formula without the prior 4 million share cap. Stockholders also elected three Class II directors to terms ending at the 2029 annual meeting and ratified Deloitte & Touche LLP as independent auditor for the 2026 fiscal year.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 5.07, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
One-time share increase: 6,509,966 shares
Evergreen rate: 4% of outstanding shares
Director vote – Amy Burroughs: 87,345,171 for / 2,943,581 withheld
+3 more
6 metrics
One-time share increase
6,509,966 shares
Approx. 3% of outstanding shares added to 2021 plan
Evergreen rate
4% of outstanding shares
Annual increase under amended 2021 Equity Incentive Plan
Director vote – Amy Burroughs
87,345,171 for / 2,943,581 withheld
Class II director election with 48,606,132 broker non-votes
Auditor ratification support
135,650,321 for
Deloitte & Touche LLP for FY ending Dec 31, 2026
Equity plan approval votes for
67,356,607 for
Amended and Restated 2021 Equity Incentive Plan
Equity plan votes against
20,575,701 against
Stockholder approval of A&R 2021 Equity Incentive Plan
Key Terms
evergreen provision, incentive stock options, broker non-votes, independent registered public accounting firm, +1 more
5 terms
evergreen provision financial
"an amendment to the annual “evergreen” provision to remove the annual limit of 4 million shares"
An evergreen provision is a clause in a financing or contract that automatically renews or replenishes the arrangement unless one party actively cancels it, like a subscription that keeps renewing each term. For investors it matters because it creates predictable, ongoing access to funding or ongoing contractual obligations — helping liquidity and planning — but can also hide long-term commitments or dilution risks if not reviewed.
incentive stock options financial
"and (3) limiting the number of shares that can be issued as incentive stock options under the plan"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
broker non-votes financial
"Name of Director Nominee | For | Withheld | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Amended and Restated 2021 Equity Incentive Plan financial
"Tenaya Therapeutics, Inc. ... amended and restated its 2021 Equity Incentive Plan"
FAQ
What did Tenaya Therapeutics (TNYA) change in its 2021 Equity Incentive Plan?
Tenaya Therapeutics amended and restated its 2021 Equity Incentive Plan, adding a one-time 6,509,966 share increase and revising the evergreen feature to a 4% of outstanding shares formula, while capping incentive stock option issuances under the plan.
How did Tenaya Therapeutics (TNYA) stockholders vote on the amended 2021 Equity Incentive Plan?
Stockholders approved the amended and restated 2021 Equity Incentive Plan with 67,356,607 votes for, 20,575,701 against, and 2,356,444 abstentions, along with 48,606,132 broker non-votes recorded for this proposal at the annual meeting.
Which directors were elected at the Tenaya Therapeutics (TNYA) 2026 annual meeting?
Stockholders elected Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen as Class II directors. Each will serve until the 2029 annual meeting and until a successor is elected and qualified, subject to earlier resignation or removal.
Who is Tenaya Therapeutics (TNYA) independent auditor for fiscal 2026?
Stockholders ratified Deloitte & Touche LLP as Tenaya Therapeutics’ independent registered public accounting firm for the year ending December 31, 2026, with 135,650,321 votes for, 2,023,657 against, and 1,220,906 abstentions and no broker non-votes.
What is the revised evergreen provision in Tenaya Therapeutics (TNYA) equity plan?
The amended plan keeps the annual increase at 4% of outstanding shares but removes the prior 4 million share cap. This evergreen feature automatically refreshes the pool of shares available for future equity awards each year.